Continuation of Research and Development Activities
First written in FY2017-Q1. . Latest entry: FY2025.
45 other companies' latest entry also says "Other".
- FY2025Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 623 tests in total, comprising 201 leather tests, 136 sole-material physical property tests, 88 processed-component delamination tests, 69 fabric and other tests, 58 sole-attachment strength tests, and 71 other tests.」
As part of its full-year research and development activities, the Company conducted 623 tests in total, and research and development expenses amounted to ¥121 million. - FY2025-H1Updated to interim-period R&D expenditureAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥54 million. There were no significant changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
Cumulative research and development expenses for the first half were updated to ¥54 million, while the Company stated that there were no material changes in its research and development activities. - FY2024Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 528 tests in total, comprising 164 leather tests, 145 sole-material physical property tests, 91 sole-attachment strength tests, 73 fabric and other tests, and 55 other tests. The Group's total research and development expenses for the consolidated fiscal year were ¥119 million.」
Full-year research and development activities were updated to 528 tests in total, and research and development expenses to ¥119 million. - FY2024-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥86 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
Cumulative research and development expenses through the third quarter were updated to ¥86 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2024-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥56 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
Cumulative research and development expenses through the second quarter were updated to ¥56 million, while the Company stated that there were no material changes in its research and development activities. - FY2024-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥27 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
Cumulative research and development expenses through the first quarter were updated to ¥27 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2023-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥77 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
Cumulative research and development expenses through the third quarter were updated to ¥77 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2023-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥51 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
Cumulative research and development expenses through the second quarter were disclosed as ¥51 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2023-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥23 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
Cumulative research and development expenses through the first quarter were updated to ¥23 million, while the Company stated that there were no material changes in its research and development activities. - FY2022Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 818 tests in total, comprising 232 leather tests, 181 sole-material physical property tests, 211 sole-attachment strength tests, 85 fabric and other tests, and 109 other tests. The Group's total research and development expenses for the consolidated fiscal year were ¥84 million.」
Full-year research and development activities were updated to 818 tests in total, and research and development expenses to ¥84 million. - FY2022-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥64 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
FY2022 cumulative research and development expenses through the third quarter were updated to ¥64 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2022-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥44 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
FY2022 cumulative research and development expenses through the second quarter were updated to ¥44 million, while the Company stated that there were no material changes in its research and development activities. - FY2022-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥23 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
FY2022 cumulative research and development expenses through the first quarter were updated to ¥23 million, while the Company stated that there were no material changes in its research and development activities. - FY2021Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 863 tests in total, comprising 240 leather tests, 207 sole-material physical property tests, 179 sole-attachment strength tests, 91 fabric and other tests, and 146 other tests. The Group's total research and development expenses for the consolidated fiscal year were ¥89 million.」
Full-year research and development activities were updated to 863 tests in total, and research and development expenses to ¥89 million. - FY2021-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥68 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
Cumulative research and development expenses through the third quarter were updated to ¥68 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2021-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥44 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
Cumulative research and development expenses through the second quarter were updated to ¥44 million, while the Company stated that there were no material changes in its research and development activities. - FY2021-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥22 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
FY2021 cumulative research and development expenses through the first quarter were updated to ¥22 million, while the Company stated that there were no material changes in its research and development activities. - FY2020Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 1,697 tests in total, comprising 518 leather tests, 395 sole-material physical property tests, 363 sole-attachment strength tests, 235 fabric and other tests, and 186 other tests. The Group's total research and development expenses for the consolidated fiscal year were ¥98 million.」
Full-year research and development activities were updated to 1,697 tests in total, and research and development expenses to ¥98 million. - FY2020-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥72 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
Cumulative research and development expenses through the third quarter were updated to ¥72 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2020-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥47 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
Cumulative research and development expenses through the second quarter were updated to ¥47 million, while the Company stated that there were no material changes in its research and development activities. - FY2020-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥23 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
FY2020 cumulative research and development expenses through the first quarter were updated to ¥23 million, while the Company stated that there were no material changes in its research and development activities. - FY2019-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥73 million.」
Cumulative research and development expenses through the third quarter were updated to ¥73 million, while the Company stated that there were no material changes in the status of its research and development activities. - FY2019-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥48 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
Cumulative research and development expenses through the second quarter were updated to ¥48 million, while the Company stated that there were no material changes in its research and development activities. - FY2019-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥24 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
FY2019 cumulative research and development expenses through the first quarter were updated to ¥24 million, while the Company stated that there were no material changes in its research and development activities. - FY2018Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 1,614 tests in total, comprising 430 leather tests, 369 sole-material physical property tests, 353 sole-attachment strength tests, 290 fabric and other tests, and 172 other tests. The Group's total research and development expenses for the consolidated fiscal year were ¥94 million.」
Full-year research and development activities were updated to 1,614 tests in total, and research and development expenses to ¥94 million. - FY2018-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥73 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
The cumulative research and development expenses through the third quarter were updated to ¥73 million, while the Company stated that there were no material changes in its research and development activities. - FY2018-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥48 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
The cumulative research and development expenses through the second quarter were updated to ¥48 million, while the Company stated that there were no material changes in its research and development activities. - FY2018-Q1Updated for cumulative research and development expenses through the first quarterAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥25 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
The cumulative research and development expenses through the first quarter were updated to ¥25 million, while the Company stated that there were no material changes in its research and development activities. - FY2017Updated for full-year research and development activities and expensesAnnual report
「During the consolidated fiscal year, the Company commissioned and evaluated 1,571 tests in total, comprising 470 leather tests, 348 sole-material physical property tests, 322 sole-attachment strength tests, 253 fabric and other tests, and 178 other tests. The Group's total research and development expenses were ¥96 million.」
As part of its full-year research and development activities, the Company conducted 1,571 tests in total and recorded ¥96 million in research and development expenses. - FY2017-Q3Updated for cumulative research and development expenses through the third quarterAnnual report
「Research and development expenses for the first 3 quarters of the current consolidated fiscal year totaled ¥71 million. There were no material changes in the status of the Group's research and development activities during the first 3 quarters of the current consolidated fiscal year.」
The cumulative research and development expenses were updated to ¥71 million, while the Company stated that there were no material changes in its research and development activities. - FY2017-Q2Updated for cumulative research and development expenses through the second quarterAnnual report
「Research and development expenses for the first half of the current consolidated fiscal year totaled ¥48 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated fiscal year.」
The cumulative research and development expenses were updated to ¥48 million, while the Company stated that there were no material changes in its research and development activities. - FY2017-Q1First statedAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year totaled ¥24 million.」
The Company disclosed research and development expenses for the quarter, stating that there were no material changes in its research and development activities.